High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902
Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2010.07.017
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2011
Authors
Publisher
Elsevier BV